Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
IDT Biologika
Manufacturing
SK Bioscience ponies up $244M for 60% stake in IDT Biologika
SK Bioscience has acquired a 60% stake in IDT Biologika, a German CDMO that specializes in vaccine production, for 339 billion won ($244 million).
Kevin Dunleavy
Jun 27, 2024 11:50am
Valneva, IDT Biologika end COVID vaccine deal as demand slides
Sep 20, 2022 9:10am
BioNTech, CureVac pledge long-term vaccine support to Germany
Mar 16, 2022 1:14pm
Pfizer, WuXi Bio, Fujifilm and more—Fierce Pharma Asia
Mar 19, 2021 9:50am
AstraZeneca taps IDT Biologika to boost Euro vaccine supplies
Feb 11, 2021 8:24am
IDT Biologika opens vaccine manufacturing facility in Germany
Jul 29, 2019 11:40am
